Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 5
1966 5
1967 10
1968 14
1969 19
1970 14
1971 16
1972 17
1973 14
1974 12
1975 21
1976 24
1977 19
1978 18
1979 13
1980 14
1981 12
1982 19
1983 28
1984 40
1985 48
1986 43
1987 45
1988 50
1989 68
1990 59
1991 84
1992 74
1993 82
1994 130
1995 119
1996 161
1997 129
1998 148
1999 154
2000 162
2001 146
2002 147
2003 175
2004 181
2005 195
2006 221
2007 233
2008 214
2009 221
2010 230
2011 245
2012 253
2013 249
2014 225
2015 278
2016 292
2017 300
2018 274
2019 267
2020 279
2021 205
Text availability
Article attribute
Article type
Publication date

Search Results

6,034 results
Results by year
Filters applied: . Clear all
Page 1
Prednisolone Versus Dexamethasone for Croup: a Randomized Controlled Trial.
Parker CM, Cooper MN. Parker CM, et al. Pediatrics. 2019 Sep;144(3):e20183772. doi: 10.1542/peds.2018-3772. Epub 2019 Aug 15. Pediatrics. 2019. PMID: 31416827 Clinical Trial.
In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone at 1 mg/kg. ...RESULTS: Mean Westley Croup Score at baseline was 1.4 for dexamethasone, 1.5 for low-dose dexamethasone, and 1.5 for pre …
In this study, we compare dexamethasone at 0.6 mg/kg with both low-dose dexamethasone at 0.15 mg/kg and prednisolone at 1 mg/k …
Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB; DART Study Investigators. Doyle LW, et al. Pediatrics. 2006 Jan;117(1):75-83. doi: 10.1542/peds.2004-2843. Pediatrics. 2006. PMID: 16396863 Clinical Trial.
There was little evidence for a reduction in either the mortality rate (dexamethasone group: 11%; control group: 20%; OR: 0.52; 95% CI: 0.14-1.95) or the rate of oxygen dependence at 36 weeks (dexamethasone group: 85%; control group: 91%; OR: 0.58; 95% CI: 0.13-2.66 …
There was little evidence for a reduction in either the mortality rate (dexamethasone group: 11%; control group: 20%; OR: 0.52; 95% C …
Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial).
DREAMS Trial Collaborators and West Midlands Research Collaborative. DREAMS Trial Collaborators and West Midlands Research Collaborative. BMJ. 2017 Apr 18;357:j1455. doi: 10.1136/bmj.j1455. BMJ. 2017. PMID: 28420629 Free PMC article. Clinical Trial.
Vomiting within 24 hours of surgery occurred in 172 (25.5%) participants in the dexamethasone arm and 223 (33.0%) allocated standard care (number needed to treat (NNT) 13, 95% confidence interval 5 to 22; P=0.003). Additional postoperative antiemetics were given (on demand …
Vomiting within 24 hours of surgery occurred in 172 (25.5%) participants in the dexamethasone arm and 223 (33.0%) allocated standard …
Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial.
Villar J, Belda J, Añón JM, Blanco J, Pérez-Méndez L, Ferrando C, Martínez D, Soler JA, Ambrós A, Muñoz T, Rivas R, Corpas R, Díaz-Dominguez FJ, Soro M, García-Bello MA, Fernández RL, Kacmarek RM; DEXA-ARDS Network. Villar J, et al. Trials. 2016 Jul 22;17:342. doi: 10.1186/s13063-016-1456-4. Trials. 2016. PMID: 27449641 Free PMC article. Clinical Trial.
Eligible patients will be randomly allocated to two arms: (i) conventional treatment without dexamethasone, (ii) conventional treatment plus dexamethasone. Patients in the dexamethasone group will be treated with a daily dose of 20 mg iv from day 1 to day 5, …
Eligible patients will be randomly allocated to two arms: (i) conventional treatment without dexamethasone, (ii) conventional treatme …
Comparison of the effects of perineural or intravenous dexamethasone on low volume interscalene brachial plexus block: a randomised equivalence trial.
McHardy PG, Singer O, Awad IT, Safa B, Henry PDG, Kiss A, Au SK, Kaustov L, Choi S. McHardy PG, et al. Br J Anaesth. 2020 Jan;124(1):84-91. doi: 10.1016/j.bja.2019.08.025. Epub 2019 Oct 5. Br J Anaesth. 2020. PMID: 31591018 Free article. Clinical Trial.
This study was designed to test whether perineural vs i.v. dexamethasone administration are equivalent. METHODS: We randomised 182 eligible patients scheduled for arthroscopic shoulder surgery to receive low-dose ISB (0.5% ropivacaine 5 ml) with perineural or i.v. dexam
This study was designed to test whether perineural vs i.v. dexamethasone administration are equivalent. METHODS: We randomised 182 el …
Determination of plasma dexamethasone in the mother and the newborn after administration of the hormone in a clinical trial.
Kream J, Mulay S, Fukushima DK, Solomon S. Kream J, et al. J Clin Endocrinol Metab. 1983 Jan;56(1):127-33. doi: 10.1210/jcem-56-1-127. J Clin Endocrinol Metab. 1983. PMID: 6336618 Clinical Trial.
The average maternal plasma dexamethasone level was 37 ng/ml 2 h after im injections of 5 mg dexamethasone phosphate every 12 h. The half-life of dexamethasone measured after the discontinuation of the drug was 216 min. ...
The average maternal plasma dexamethasone level was 37 ng/ml 2 h after im injections of 5 mg dexamethasone phosphate every 12 …
Dexamethasone solution and dexamethasone in Mucolox for the treatment of oral lichen planus: a preliminary study.
Villa A, Sankar V, Bassani G, Johnson LB, Sroussi H. Villa A, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jun;129(6):585-590. doi: 10.1016/j.oooo.2020.02.014. Epub 2020 Mar 25. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020. PMID: 32220595 Clinical Trial.
OBJECTIVE: The objective of this single-center, open-label, randomized, phase II study was to evaluate the safety and efficacy of dexamethasone 0.1 mg/mL solution in Mucolox (arm A) compared with dexamethasone 0.1 mg/mL solution alone (arm B) for treatment of oral l …
OBJECTIVE: The objective of this single-center, open-label, randomized, phase II study was to evaluate the safety and efficacy of dexamet
DEX-2-TKA-DEXamethasone twice for pain treatment after Total Knee Arthroplasty: A protocol for a randomized, blinded, three-group multicentre clinical trial.
Gasbjerg KS, Hägi-Pedersen D, Lunn TH, Jakobsen JC, Overgaard S, Pedersen NA, Bagger J, Lindholm P, Brorson S, Schrøder HM, Thybo KH, Mathiesen O. Gasbjerg KS, et al. Acta Anaesthesiol Scand. 2020 Feb;64(2):267-275. doi: 10.1111/aas.13481. Epub 2019 Oct 18. Acta Anaesthesiol Scand. 2020. PMID: 31544230 Clinical Trial.
AIM: To investigate the beneficial and harmful effects of one or two doses of 24 mg intravenous dexamethasone (DXM) as part of a multimodal analgesic regimen (paracetamol, NSAID and perioperative local infiltration analgesia) after TKA. We hypothesize that addition of DXM …
AIM: To investigate the beneficial and harmful effects of one or two doses of 24 mg intravenous dexamethasone (DXM) as part of a mult …
Comparison of intraperitoneal versus intravenous dexamethasone on postoperative nausea and vomiting after gynecological laparoscopy: a randomized clinical trial.
Ismail EA, Abo Elfadl GM, Bahloul M. Ismail EA, et al. Korean J Anesthesiol. 2019 Feb;72(1):47-52. doi: 10.4097/kja.d.18.00132. Epub 2018 Sep 18. Korean J Anesthesiol. 2019. PMID: 30223315 Free PMC article. Clinical Trial.
This study compared the effect of intraperitoneal versus intravenous dexamethasone for reducing PONV after gynecological laparoscopic surgeries. ...CONCLUSIONS: Intraperitoneal dexamethasone at a dose of 8 mg at the end of gynecological laparoscopy reduces the incid …
This study compared the effect of intraperitoneal versus intravenous dexamethasone for reducing PONV after gynecological laparoscopic …
DEX-2-TKA - DEXamethasone twice for pain treatment after Total Knee Arthroplasty: Detailed statistical analysis plan for a randomized, blinded, three-group multicentre clinical trial.
Gasbjerg KS, Hägi-Pedersen D, Lunn TH, Overgaard S, Pedersen NA, Bagger J, Lindholm P, Brorson S, Schrøder HM, Thybo KH, Mathiesen O, Jakobsen JC. Gasbjerg KS, et al. Acta Anaesthesiol Scand. 2020 Jul;64(6):839-846. doi: 10.1111/aas.13560. Epub 2020 Mar 3. Acta Anaesthesiol Scand. 2020. PMID: 32048274 Clinical Trial.
Participants will be randomized to one of three intervention groups: single dose of iv dexamethasone 24 mg, two consecutive doses of iv dexamethasone 24 mg or matching iv placebo. ...DISCUSSION: The DEX-2-TKA trial will provide high quality data regarding benefits a …
Participants will be randomized to one of three intervention groups: single dose of iv dexamethasone 24 mg, two consecutive doses of …
6,034 results